New Delhi: Renal care provider Nephro Care India Ltd on Tuesday said it is looking to raise a little over Rs 41 crore through its initial share sale, which will open for public subscription on June 28.
The issue, with a price band of Rs 85 to Rs 90 per share, will conclude on July 2. Bidding for anchor investors will open for one day on June 27, the Kolkata-based healthcare provider said in a statement.
The IPO comprises a fresh issue of 45.84 lakh shares worth Rs 41.26 crore at the upper end of the price band. After the issue, the company's shares will be listed on the NSE Emerge platform.
The kidney care provider intends to use Rs 26.17 crore of the IPO proceeds to set up a multi-specialty healthcare facility, Vivacity Multi Specialty Hospital, at Madhyamgram in Kolkata, West Bengal, and the capital remainder will be used for general corporate expenses. purposes.
The new hospital is proposed to include 100 inpatient beds, including a 30-bed critical care unit. The new hospital will offer treatment services in various disciplines such as cardiology, medical oncology, gastroenterology, gynecology and many others, including an advanced kidney transplant unit in eastern India.
In December 2023, Nephro Care India successfully closed pre-IPO funding round, which included banking veteran and former HDFC Ltd Chairman Deepak Parekh, HDFC Securities Chairman Bharat Shah, and Founder and Director CEO of Macleods Pharmaceuticals, Rajendra Agarwal, among others. .
In financial terms, Nephro Care India recorded a revenue of Rs 19.75 crore and made a profit (PAT) of Rs 3.4 crore during the first nine months of the financial year 2023-24.
Corporate Capital Ventures is the lead book-running manager and Bigshare Services Private Ltd is the registrar to the issue.
The issue, with a price band of Rs 85 to Rs 90 per share, will conclude on July 2. Bidding for anchor investors will open for one day on June 27, the Kolkata-based healthcare provider said in a statement.
The IPO comprises a fresh issue of 45.84 lakh shares worth Rs 41.26 crore at the upper end of the price band. After the issue, the company's shares will be listed on the NSE Emerge platform.
The kidney care provider intends to use Rs 26.17 crore of the IPO proceeds to set up a multi-specialty healthcare facility, Vivacity Multi Specialty Hospital, at Madhyamgram in Kolkata, West Bengal, and the capital remainder will be used for general corporate expenses. purposes.
The new hospital is proposed to include 100 inpatient beds, including a 30-bed critical care unit. The new hospital will offer treatment services in various disciplines such as cardiology, medical oncology, gastroenterology, gynecology and many others, including an advanced kidney transplant unit in eastern India.
In December 2023, Nephro Care India successfully closed pre-IPO funding round, which included banking veteran and former HDFC Ltd Chairman Deepak Parekh, HDFC Securities Chairman Bharat Shah, and Founder and Director CEO of Macleods Pharmaceuticals, Rajendra Agarwal, among others. .
In financial terms, Nephro Care India recorded a revenue of Rs 19.75 crore and made a profit (PAT) of Rs 3.4 crore during the first nine months of the financial year 2023-24.
Corporate Capital Ventures is the lead book-running manager and Bigshare Services Private Ltd is the registrar to the issue.
